Improved survival following transarterial radioembolization of infiltrative-appearance hepatocellular carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology
Link
https://link.springer.com/content/pdf/10.1007/s00261-020-02870-3.pdf
Reference28 articles.
1. Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D, et al (2013) The Global Burden of Cancer. JAMA Oncol 1:505-527
2. Goutte N, Sogni P, Bendersky N, Barbare JC, Falissard B, Farges O (2017) Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country. J Hepatol 66:537-544
3. Petrick JL, Kelly SP, Altekruse SF, McGlynn KA, Rosenberg PS (2016) Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030. J Clin Oncol 34:1787-1794
4. Kojiro M (2005) Histopathology of liver cancers. Best Pract Res Clin Gastroenterol 19:39-62
5. Jakate S, Yabes A, Giusto D, et al (2010) Diffuse cirrhosis-like hepatocellular carcinoma: a clinically and radiographically undetected variant mimicking cirrhosis. Am J Surg Pathol 34:935-941
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hepatic Arterial Infusion Chemotherapy Combined Lenvatinib and PD-1 Inhibitor Showed Improved Survival for Infiltrative Hepatocellular Carcinoma: A Multicenter Cohort Study;Journal of Hepatocellular Carcinoma;2024-09
2. Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective Study;ImmunoTargets and Therapy;2024-08
3. 2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations;Journal of Clinical and Experimental Hepatology;2024-01
4. Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis;Clinical and Molecular Hepatology;2023-07-01
5. Diffuse infiltrative hepatocellular carcinoma: Multimodality imaging manifestations;Journal of Surgical Oncology;2022-11-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3